Trial Search Results

Cognitive Behavioral Therapy in Treating Anxiety in Patients With Stage IV Non-Small Cell Lung Cancer and Their Caregivers

This pilot clinical trial studies cognitive behavioral therapy in treating anxiety in patients with stage IV non-small cell lung cancer and their caregivers. Cognitive behavioral therapy may reduce anxiety and improve the well-being and quality of life of patients who have stage IV non-small cell lung cancer and their caregivers.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Cancer Institute (NCI)

Intervention(s):

  • Other: counseling intervention
  • Other: questionnaire administration
  • Procedure: quality-of-life assessment

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Diagnosis of stage IV non-small cell lung cancer

   - At least 6 weeks post-diagnosis

   - Current symptoms of anxiety (e.g., Hamilton Rating Scale for Anxiety [HAM-A] >=14)

   - Ability to understand and the willingness to sign a written informed consent document

   - CAREGIVER: Identified by patient as primary caregiver

   - CAREGIVER: At least 14 hours/week spent caring for patient

   - CAREGIVER: Current symptoms of anxiety (e.g., HAM-A >= 14)

   - CAREGIVER: Ability to understand and the willingness to sign a written informed
   consent document

Exclusion Criteria:

   - PATIENTS AND CAREGIVERS:

   - Active, unstable, untreated serious mental illness

   - Other cognitive inability to complete informed consent process or study procedures

Ages Eligible for Study

N/A - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
ccto-office@stanford.edu
650-498-7061